Tag: HIV; PrEP; Lenacapavir; Gilead; South Africa; Department Of Health; SAHPRA; Public Health; Health Policy; Budget Vote; Infrastructure; Hospitals; NHI; Governance; Procurement; Key Populations.

South Africa will begin providing Gilead’s long-acting HIV prevention injection, lenacapavir, on 5 June 2026, Health Minister Aaron Motsoaledi told Parliament during his department’s budget vote. The twice-yearly shot serves as a major new tool for prevention. This follows trial data, which showed near-complete protection against HIV when used as PrEP. Motsoaledi said the country could “eliminate HIV/Aids as a…